Cheyne Capital Management (UK) LLP / XENE
Cheyne Capital Management (UK) LLP’s Xenon Pharmaceuticals Inc Position
Does Cheyne Capital Management (UK) LLP own Xenon Pharmaceuticals Inc (XENE)? Not currently — the last reported position was 42.5K shares worth $2M in Q4 2022; the fund’s latest 13F (Q4 2023) no longer reports it.
Position Value
$2M
Q4 2022
Shares
42.5K
% of Portfolio
+2.93%
Quarters Held
1
position exited
Position History XENE
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2022 | 42.5K | $2M | +2.93% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cheyne Capital Management (UK) LLP’s full portfolio or all institutional holders of XENE.